Invega Sustenna Injection 75mg - Long Acting Antipsychotic for Schizophrenia
Invega Sustenna Injection 75mg
Invega Sustenna is a long-acting injectable antipsychotic medication designed for the treatment of schizophrenia in adults. This formulation of paliperidone palmitate offers a convenient once-monthly dosing schedule, helping to improve adherence and manage symptoms effectively.
Key Features- Long-acting formulation for monthly administration
- Effective in managing symptoms of schizophrenia
- Administered via intramuscular injection
- Active Ingredient Paliperidone Palmitate
- Dosage 75mg
- Administration Intramuscular (IM)
Invega Sustenna is primarily used for the treatment of schizophrenia in adults, providing a long-term solution for symptom management.
Typical User/Industry ProfileHealthcare professionals prescribing antipsychotic treatments for adult patients with schizophrenia.
About the BrandInvega Sustenna is developed by Janssen Pharmaceuticals, a leader in mental health treatments, known for their innovative solutions in antipsychotic medications.
Original: $229.49
-65%$229.49
$80.32Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Invega Sustenna Injection 75mg
Invega Sustenna is a long-acting injectable antipsychotic medication designed for the treatment of schizophrenia in adults. This formulation of paliperidone palmitate offers a convenient once-monthly dosing schedule, helping to improve adherence and manage symptoms effectively.
Key Features- Long-acting formulation for monthly administration
- Effective in managing symptoms of schizophrenia
- Administered via intramuscular injection
- Active Ingredient Paliperidone Palmitate
- Dosage 75mg
- Administration Intramuscular (IM)
Invega Sustenna is primarily used for the treatment of schizophrenia in adults, providing a long-term solution for symptom management.
Typical User/Industry ProfileHealthcare professionals prescribing antipsychotic treatments for adult patients with schizophrenia.
About the BrandInvega Sustenna is developed by Janssen Pharmaceuticals, a leader in mental health treatments, known for their innovative solutions in antipsychotic medications.
